DNA testing could make cancer drugs safer for kids
NCT ID NCT06744712
First seen Jun 27, 2026 · Last updated Jul 23, 2026 · Updated 3 times
Summary
This study looks at how a child's genes affect the way their body processes cancer medications. By testing 130 children and young adults (up to age 26) with newly diagnosed cancer, researchers hope to find genetic differences that could help doctors choose safer and more effective drug doses. The goal is to reduce harmful side effects and improve treatment outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Levine Childrens Hospital Pediatric Cancer and Blood Disorders
Charlotte, North Carolina, 28203, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood test may foretell Radiation's toll on the gut
- Can a Tumor's genetic blueprint guide better treatment for kids with brain cancer?
- Can immune checkpoint drugs fight cancers beyond their approved uses?
- Can a shorter chemo combo tame High-Risk neuroblastoma?
- Virtual companion 'Ida' may ease cancer distress in kids
- Can off-label cancer drugs help children? a national study aims to find out